Weak D Type 102 Found in a Family Study: The First Case in Korea

Beomki Lee, Yoo Na Chung, HongBi Yu, Tae Yeul Kim, Kwang-Mo Choi, D. Cho
{"title":"Weak D Type 102 Found in a Family Study: The First Case in Korea","authors":"Beomki Lee, Yoo Na Chung, HongBi Yu, Tae Yeul Kim, Kwang-Mo Choi, D. Cho","doi":"10.17945/kjbt.2020.31.2.153","DOIUrl":null,"url":null,"abstract":"Weak D type 102 allele (RHD*01W.102) carrying a missense variant (c.73A>T, p.Ile25Phe) in exon 1 of the RHD has not been reported in Koreans to date. This is the first report of the weak D type 102 allele in the Korean population. The proposita, a 35-year-old woman, showed a serological weak D phenotype in routine RhD typing. Sequencing of all 10 RHD exons and zygosity testing targeting the hybrid Rhesus box revealed this proposita to harbor the weak D type 102 allele, as well as an RHD deletion (RHD*01W.102/RHD*01N.01). Family studies showed that the weak D type 102 allele was also present in her father and older brother (both assumed to be RHD*01W.102/RHD*01) but not in her mother and oldest brother (both assumed to be RHD*01/RHD*01N.01). In silico analysis of the replacement of isoleucine by phenylalanine at position 25 was done with PolyPhen-2, SIFT, and PROVEAN. While PolyPhen-2 predicted the variant as benign, SIFT and PROVEAN predicted it as damaging and deleterious, respectively, suggesting RHD c.73A>T (I25F) as the cause of serologic weak D phenotype. This patient should be treated as D-negative, when transfusion is needed. (Korean J Blood Transfus 2020;31:153-158)","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean Journal of Blood Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17945/kjbt.2020.31.2.153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Weak D type 102 allele (RHD*01W.102) carrying a missense variant (c.73A>T, p.Ile25Phe) in exon 1 of the RHD has not been reported in Koreans to date. This is the first report of the weak D type 102 allele in the Korean population. The proposita, a 35-year-old woman, showed a serological weak D phenotype in routine RhD typing. Sequencing of all 10 RHD exons and zygosity testing targeting the hybrid Rhesus box revealed this proposita to harbor the weak D type 102 allele, as well as an RHD deletion (RHD*01W.102/RHD*01N.01). Family studies showed that the weak D type 102 allele was also present in her father and older brother (both assumed to be RHD*01W.102/RHD*01) but not in her mother and oldest brother (both assumed to be RHD*01/RHD*01N.01). In silico analysis of the replacement of isoleucine by phenylalanine at position 25 was done with PolyPhen-2, SIFT, and PROVEAN. While PolyPhen-2 predicted the variant as benign, SIFT and PROVEAN predicted it as damaging and deleterious, respectively, suggesting RHD c.73A>T (I25F) as the cause of serologic weak D phenotype. This patient should be treated as D-negative, when transfusion is needed. (Korean J Blood Transfus 2020;31:153-158)
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在家庭研究中发现的弱D型102:韩国的第一例
弱D型102等位基因(RHD*01W.102)在RHD外显子1携带错义变体(c.73A>T, p.Ile25Phe),迄今未在韩国人中报道。这是首次在韩国人群中发现弱D型102等位基因。申请人,一名35岁的女性,在常规RhD分型中显示血清学弱D表型。对所有10个RHD外显子的测序和针对杂交恒河猴盒子的合子性测试表明,该基因含有弱D型102等位基因,以及RHD缺失(RHD*01W.102/RHD*01N.01)。家庭研究表明,弱D型102等位基因在其父亲和哥哥(均为RHD*01W.102/RHD*01)中也存在,但在其母亲和哥哥(均为RHD*01/RHD*01N.01)中不存在。用polyphen2、SIFT和PROVEAN进行了25位苯丙氨酸取代异亮氨酸的硅分析。polyphen2预测该变异为良性,而SIFT和PROVEAN分别预测其为破坏性和有害性,提示RHD c.73A>T (I25F)是血清学弱D表型的原因。当需要输血时,该患者应作为d阴性治疗。(韩国输血杂志2020;31:153-158)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Changes in the Korean Journal of Blood Transfusion over Three Years (2021 to 2023) Unexpected Antibody Identification Experienced by a Referral Laboratory for Medical Testing Daratumumab-Induced Interference in Flow-Cytometry Crossmatch and Resolving It by DTT Treatment Comparison of Unexpected Antibody Frequency in Korea by Department: Focusing on Obstetrics and Infertility Centers Suggestion to Use Optimal ABO Non-Identical but Compatible RBC Components in Emergency/Massive Transfusions: Are Type O RBC the Second Best for Type AB Patients?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1